These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28190637)

  • 1. The National Institute for Health and Care Excellence (NICE) Guidance on Bladder Cancer; a Step in the Right Direction?
    Trainor S; Choudhury A; Huddart R; Kiltie AE; Kockelbergh R; Turner W; Birtle A; Crabb SJ
    Clin Oncol (R Coll Radiol); 2017 Jun; 29(6):344-347. PubMed ID: 28190637
    [No Abstract]   [Full Text] [Related]  

  • 2. Appraisal of Novel Oncological Therapies by the Scottish Medicines Consortium and the National Institute for Health and Care Excellence: A Comparative Study of Six Years of Data.
    Taylor R
    Cureus; 2023 Dec; 15(12):e50560. PubMed ID: 38222244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
    Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
    Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Institute for Health and Care Excellence (NICE) guidance on heart valve disease.
    Shah BN
    Heart; 2023 May; 109(11):817-822. PubMed ID: 36653169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current application of National Institute for Health and Clinical Excellence (NICE) guidance in the management of patients with severe psoriasis: a clinical audit against NICE guidance in seven National Health Service specialist dermatology units in England.
    Bewley A; Cerio R; Clement M; Hunt S; Lucke T; Ratnavel R; Walton S; Percival F
    Clin Exp Dermatol; 2011 Aug; 36(6):602-6. PubMed ID: 21392078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populations.
    Wong LM; Johnston R; Sharma N; Shah NC; Warren AY; Neal DE
    BJU Int; 2012 Jul; 110(1):24-7. PubMed ID: 22077729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NICE and LICE: lessons from a health district. National Institute for Clinical Excellence. Local institutes of clinical excellence.
    Madhok R; Taylor A; Soltani H; Ireland K
    J Public Health Med; 2002 Mar; 24(1):2-5. PubMed ID: 11939377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer: review of the National Institute for Clinical Excellence (NICE) guidance recommendations.
    Johnston SR
    Cancer Invest; 2004; 22(5):730-42. PubMed ID: 15581055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Dawn for Bladder Cancer? Recommendations from the National Institute for Health and Care Excellence (NICE) on Managing Bladder Cancer.
    Huddart RA; Jones R; Choudhury A
    Clin Oncol (R Coll Radiol); 2015 Jul; 27(7):380-1. PubMed ID: 25869257
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of the National Institute for Health and Care Excellence (NICE) guidance on medical technology uptake: analysis of the uptake of spinal cord stimulation in England 2008-2012.
    Vyawahare B; Hallas N; Brookes M; Taylor RS; Eldabe S
    BMJ Open; 2014 Jan; 4(1):e004182. PubMed ID: 24398364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prioritising public health guidance topics in the National Institute for Health and Care Excellence using the Analytic Hierarchy Process.
    Reddy BP; Kelly MP; Thokala P; Walters SJ; Duenas A
    Public Health; 2014 Oct; 128(10):896-903. PubMed ID: 25369354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the influence of the publication of the UK National Institute for health and Care Excellence's guidance on hypertension in pregnancy: a retrospective analysis of clinical practice.
    Farrar D; Tuffnell D; Sheldon TA
    BMC Pregnancy Childbirth; 2020 Feb; 20(1):101. PubMed ID: 32050920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Views of Directors of Public Health about NICE Appraisal Guidance: results of a postal survey. National Institute for Clinical Excellence.
    Davies E; Littlejohns P
    J Public Health Med; 2002 Dec; 24(4):319-25. PubMed ID: 12546211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicine characteristics affecting the time to guidance publication by National Institute for Health and Care Excellence in the single technology appraisal process.
    Takada S; Narukawa M
    Int J Technol Assess Health Care; 2021 Dec; 38(1):e11. PubMed ID: 34933699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Technology Assessment-Informed Decision Making by the Federal Joint Committee/Institute for Quality and Efficiency in Health Care in Germany and the National Institute for Health and Care Excellence in England: The Role of Budget Impact.
    Schaefer R; Hernández D; Bärnighausen T; Kolominsky-Rabas P; Schlander M
    Value Health; 2023 Jul; 26(7):1032-1044. PubMed ID: 36921901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NICE update NICE public health guidance update.
    Roberts S; Nolan K; Shearn P; Raynor M; Leng G
    J Public Health (Oxf); 2020 Nov; 42(4):857-860. PubMed ID: 31884519
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.